The myeloperoxidase-463 G>a polymorphism influences risk of colorectal cancer in southern China: A case-control study

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 7, 2011, Pages 1789-1793

  Li, Ying ^a   Qin, Yuan ^b   Wang, Mei Lin ^a   Zhu, Huan Feng ^c   Huang, Xin En ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal cancer; Myeloperoxidase; Polymorphism

Indexed keywords

PEROXIDASE; REACTIVE OXYGEN METABOLITE;

ADENOMA; ARTICLE; CASE CONTROL STUDY; CHINA; COLORECTAL TUMOR; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; OXIDATIVE STRESS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOMA; CASE-CONTROL STUDIES; CHINA; COLORECTAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PEROXIDASE; POLYMORPHISM, SINGLE NUCLEOTIDE; REACTIVE OXYGEN SPECIES; RISK FACTORS;

EID: 84864352626     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ahn J, Gammon MD, Santella RM, et al (2004). Myeloperoxidase genotype, fruit and vegetable consumption, and breast cancer risk. Cancer Res, 64, 7634-9.
2. Austin GE, Lam L, Zaki SR, et al (1993). Sequence comparison of putative regulatory DNA of 5' flanking region of the myeloperoxidase gene in normal and leukemic bone marrow cells. Leukemia, 7, 1445-50.
3. Cascorbi I, Henning S, Brockmöller J, et al (2000). Substantially reduced risk of cancer of the aerodigestive tract in subjects with variant-463A of the myeloperoxidase gene. Cancer Res, 60, 644-9.
4. He J, Gu D, Wu X, et al (2005). Major causes of death among men and women in China. N Engl J Med, 353, 1124-34.
5. Hung RJ, Boffetta P, Brennan P, et al (2004). Genetic polymorphisms of MPO, COMT,MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis, 25, 973-8.
6. Johansson SL, Cohen SM (1997). Epidemiology and etiology of bladder cancer. Semin Surg Oncol, 13, 291-8.
7. Kiyohara C, Yoshimasu K, Takayama K, et al (2005). NQO1, MPO, and the risk of lung cancer: a HuGE review. Genet Med, 7, 463-78.
8. Le M, Seifried A, Lum A, et al (2000). Association of the myeloperoxidase-463G>A polymorphism with lung cancer risk. Cancer Epidemiol Biomarkers Prev, 9, 181-4.
9. Lijinsky W, Thomas BJ, Kovatch RM (1992). Systemic and local carcinogenesis by directly acting N-nitroso compounds givento rats by intravesicular administration. Carcinogenesis, 13, 1101-5.
10. Lu W, Xing D, Qi J, et al (2002). Genetic polymorphism in myeloperoxidase but not GSTM1 is associated with risk of lung squamous cell carcinoma in a Chinese population. Int J Cancer, 102, 275-9.
11. McKenzie SJ, Baker MS, Buffinton GD, et al (1996). Evidence of oxidant-induced injury to epithelial cells during inflammatory bowel disease. J Clin Invest, 98, 136-41.
12. Moskal A, Norat T, Ferrari P, et al (2007). Alcohol intake and colorectal cancer risk: A dose-response meta-analysis of published cohort studies. Int J Cancer, 120, 664-71.
13. Ohnishi S, Murata M, and Kawanishi S (2002). DNA damage induced by hypochlorite and hypobromite with reference to inflammation-associated carcinogenesis. Cancer Lett, 178, 37-42.
14. Petruska JM, Mosebrook DR, Jakab GJ, et al (1992). Myeloperoxidase-enhanced formation of (+-)-trans-7,8-dihydroxy-7,8- dihydrobenzo[a]pyrene-DNA adducts in lung tissue in vitro: a role of pulmonary inflammation in the bioactivation of procarcinogen. Carcinogenesis, 13, 1075-81.
15. Piedrafita FJ, Molander RB, Vansant G, et al (1996). An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J Biol Chem, 271, 14412-20.
16. Pöschl G, Seitz HK (2004). Alcohol and cancer. Alcohol Alcohol, 39, 155-65.
17. Reynolds WF, Hiltunen M, Pirskanen M, et al (2000). MPO and APOEepsilon4 polymorphisms interact to increase risk for AD in Finnish males. Neurology, 55, 1284-90.
18. Riley GF, Potosky AL, Lubitz JD, et al (1995). Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis. Med Care, 33, 828-41.
19. Rojas M, Godschalk R, Alexandrov K, et al (2001). Myeloperoxidase 463A variant reduces benzo[a]pyrene diol epoxide DNA adducts in skin of coal tar treated patients. Carcinogenesis, 22, 1015-8.
20. Schabath MB,Spitz MR, Hong WK, et al (2002). A myeloperoxidase polymorphism associated with reduced risk of lung cancer. Lung Cancer, 37, 35-40.
21. Shama C. Buch, PhD. Case-Control Study of Oral And Oropharyngeal Cancer in Whites and Genetic Variation in Eight Metabolic Enzymes. Head Neck, 30, 1139-47.
22. Skuladottir H, Autrup H, Autrup J, et al (2005). Polymorphisms in genesinvolved in xenobiotic metabolism and lung cancer risk under the age of 60 years. A pooled study of lung cancer patients in Denmark and Norway. Lung Cancer, 48, 187-99.
23. Steenport M, Eom H, Uezu M, et al (2007). Association of polymorphisms in myeloperoxidase and catalase genes with precancerous changes in the gastric mucosa of patients at innercity hospitals in New York. Oncol Rep, 18, 235-40.
24. Whiteman M, Jenner A, Halliwell B (1997). Hypochlorous acidinduced base modifications in isolated calf thymus DNA. Chem Res Toxicol, 10, 1240-6.
25. Whiteman M, Spencer JP, Jenner A, Halliwell B (1999). Hypochlorous acid-induced DNA base modification: potentiation by nitrite: biomarkers of DNA damage by reactive oxygen species. Biochem Biophys Res Commun, 257, 572-6.
26. World Gastroenterology Organization/International Digestive Cancer Alliance(2007): Practice Guidelines: Colorectal Cancer Screening World Gastroenterology Organization
27. Xu LL, Liu G, Miller DP, et al (2002) Counterpoint: the myeloperoxidase -463G-->a polymorphism does not decrease lung cancer susceptibility in Caucasians. Cancer Epidemiol Biomarkers Prev, 11, 1555-9.
28. Yang J, Ambrosone CB, Hong CC, et al (2007). Relationships between polymorphisms in NOS3 and MPO genes,cigarette smoking and risk of post-menopausal breast cancer. Carcinogenesis, 28, 1247-53.
29. Yang M, Choi Y, Hwangbo B, et al (2007). Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung Cancer, 57, 135-42.
30. Zhu H, Yang L, et al (2006). Myeloperoxidase G-463A polymorphism and the risk of gastric cancer: a case-control study. Carcinogenesis, 27, 2491-6.